
Efficacy and safety of sugammadex versus neostigmine in reversing neuromuscular blockade in morbidly obese adult patients: A systematic review and meta-analysis
Author(s) -
Yamini Subramani,
Jill Querney,
Susan He,
Mahesh Nagappa,
H. Keri Yang,
Ashraf Fayad
Publication year - 2021
Publication title -
al-banǧ. maqālāt wa abḥāṯ fī al-taẖdīr wa-al-in’āš
Language(s) - English
Resource type - Journals
ISSN - 0259-1162
DOI - 10.4103/aer.aer_79_21
Subject(s) - sugammadex , neostigmine , medicine , anesthesia , confidence interval , neuromuscular blockade , adverse effect , odds ratio , meta analysis , rocuronium , intubation
Sugammadex is known to reverse neuromuscular blockade (NMB) more rapidly and reliably than neostigmine. However, data remain limited in bariatric patients. In this review, we systematically evaluated the efficacy and safety of sugammadex versus neostigmine in reversing NMB in morbidly obese (MO) patients undergoing bariatric surgery.